{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T19:18:01Z","timestamp":1773775081916,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key Program of Mega Infectious Diseases"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ijantimicag.2014.09.013","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T13:32:49Z","timestamp":1413984769000},"page":"124-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drug resistance characteristics of Mycobacterium tuberculosis isolates to four first-line antituberculous drugs from tuberculosis patients with AIDS in Beijing, China"],"prefix":"10.1016","volume":"45","author":[{"given":"Gui-ju","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-zhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-lin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-wang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0005","series-title":"Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0010","series-title":"Global tuberculosis report 2012","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0015","series-title":"HIV-associated TB facts 2013","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0020","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1164\/ajrccm.154.5.8912768","article-title":"The impact of human immunodeficiency virus infection on drug-resistant tuberculosis","volume":"154","author":"Gordin","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0025","doi-asserted-by":"crossref","first-page":"e5561","DOI":"10.1371\/journal.pone.0005561","article-title":"Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review","volume":"4","author":"Suchindran","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0030","doi-asserted-by":"crossref","first-page":"e15735","DOI":"10.1371\/journal.pone.0015735","article-title":"Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community","volume":"5","author":"Andrews","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0035","first-page":"504","article-title":"Twenty-five years of tuberculosis in a French university hospital: a laboratory perspective","volume":"4","author":"Robert","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0040","first-page":"877","article-title":"Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin","volume":"2","author":"Park","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1758-2652-11-6","article-title":"Confronting TB\/HIV in the era of increasing anti-TB drug resistance","volume":"11","author":"Chakaya","year":"2008","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0050","first-page":"305","article-title":"HIV co-infection with tuberculous and non-tuberculous mycobacteria in western Kenya: challenges in the diagnosis and management","volume":"12","author":"Nyamogoba","year":"2012","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0055","series-title":"Progress report 2011: global HIV\/AIDS response. Epidemic update and health sector progress towards universal access","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0060","series-title":"TB volume of clinical diagnosis and treatment guidelines","author":"Chinese Medical Association","year":"2005"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0065","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1128\/JCM.41.4.1637-1650.2003","article-title":"PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions","volume":"41","author":"Huard","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0070","first-page":"659","article-title":"Rapid species identification of 391 clinical Mycobacterium isolates from Anhui Province by multi-locus PCR","volume":"28","author":"Bao","year":"2012","journal-title":"Chin J Zoonoses"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0075","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1183\/09031936.03.00014103","article-title":"Multidrug-resistant tuberculosis: eight years of surveillance in France","volume":"22","author":"Robert","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0080","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3201\/eid0912.020731","article-title":"Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru","volume":"9","author":"Campos","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0085","first-page":"887","article-title":"Determinants of drug-resistant tuberculosis: analysis of 11 countries","volume":"5","author":"Espinal","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0090","first-page":"1516","article-title":"Drug sensitivity testing of MTB in AIDS coinfection patients","volume":"31","author":"Meng","year":"2009","journal-title":"Guangxi Med J"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0095","first-page":"819","article-title":"Clinical research between AIDS and tuberculosis with multi-drug resistance","volume":"15","author":"Tang","year":"2010","journal-title":"J Clin Pulmon Med"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0100","first-page":"763","article-title":"Drug resistance and HIV co-infection among pulmonary tuberculosis patients in Haiphong City, Vietnam","volume":"12","author":"Khe","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2014.09.013_bib0105","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1086\/518665","article-title":"HIV infection and multidrug-resistant tuberculosis: the perfect storm","volume":"196","author":"Wells","year":"2007","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2014.09.013_bib0110","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.2105\/AJPH.2009.170142","article-title":"HIV\u2013tuberculosis coinfection in Southern California: evaluating disparities in disease burden","volume":"100","author":"Rodwell","year":"2010","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/S0037-86822004000100012","article-title":"Characteristics of pulmonary tuberculosis in HIV seropositive and seronegative patients in a northeastern region of Brazil","volume":"37","author":"Liberato","year":"2004","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10096-008-0627-y","article-title":"Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain","volume":"28","author":"Su\u00e1rez-Garc\u00eda","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0125","first-page":"903","article-title":"Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia","volume":"7","author":"Morozova","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/thx.2005.045963","article-title":"Risk factors for multidrug resistant tuberculosis in Europe: a systematic review","volume":"61","author":"Faustini","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0135","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1258\/ijsa.2008.008379","article-title":"First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran","volume":"20","author":"Tabarsi","year":"2009","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0140","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4103\/0971-5916.92630","article-title":"Diagnosis & treatment of tuberculosis in HIV co-infected patients","volume":"134","author":"Padmapriyadarsini","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0145","first-page":"739","article-title":"Cause and treatment of multi-drug resistant pulmonary tuberculosis in patients with HIV infection","volume":"11","author":"Zheng","year":"2005","journal-title":"Chin J Rehabil Theor Pract"},{"key":"10.1016\/j.ijantimicag.2014.09.013_bib0150","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1128\/AAC.48.11.4473-4475.2004","article-title":"Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease","volume":"48","author":"Gurumurthy","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914003045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914003045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T05:50:53Z","timestamp":1538113853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857914003045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0924857914003045"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.09.013","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug resistance characteristics of Mycobacterium tuberculosis isolates to four first-line antituberculous drugs from tuberculosis patients with AIDS in Beijing, China","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}